Claudine Bruck - Nov 20, 2023 Form 4/A - Amendment Insider Report for Annovis Bio, Inc. (ANVS)

Role
Director
Signature
/s/ Henrey Hagopian III, Attorney-in-Fact for Claudine Bruck
Stock symbol
ANVS
Transactions as of
Nov 20, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
11/22/2023, 04:14 PM
Date Of Original Report
Nov 21, 2023
Previous filing
Jul 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANVS Common Stock Other $0 0 0% $0.00* 6.57K Nov 20, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed solely to reverse the previously reported purchase on the original form 4 filed on November 21, 2023 (the "Original Form 4"). Such purchase was rescinded by the registrant and the reporting person on November 22, 2023.